What fasting (pre‑breakfast) blood glucose target should be used for an adult patient on basal insulin, taking into account age, comorbidities, and hypoglycemia risk?

Fasting Blood Glucose Goal for Patients on Basal Insulin

For most adult patients on basal insulin, target a fasting blood glucose of 90-150 mg/dL (5.0-8.3 mmol/L), with the understanding that this range should be adjusted based on the patient's age, comorbidity burden, hypoglycemia risk, and functional status. 1, 2

Standard Target Range

The most recent ADA guidelines (2024-2025) consistently recommend a fasting glucose goal of 90-150 mg/dL (5.0-8.3 mmol/L) when titrating basal insulin 1, 2. This target appears repeatedly across multiple years of guidelines, particularly in algorithms for simplifying insulin therapy in older adults, but applies broadly to adult populations.

Titration Strategy

When adjusting basal insulin doses:

• Increase by 2 units if 50% or more of fasting glucose values exceed the goal over one week
• Decrease by 2 units if more than 2 fasting values per week fall below 80 mg/dL (4.4 mmol/L) 1, 2

This creates a practical safety threshold at 80 mg/dL to prevent hypoglycemia while maintaining the upper target at 150 mg/dL.

More Aggressive Targets for Select Patients

For younger, healthier patients without significant comorbidities or hypoglycemia risk, research supports more ambitious targets:

• A 2022 systematic analysis found that targeting FPG ≤5.6 mmol/L (100 mg/dL) achieved better HbA1c control without increasing hypoglycemia risk 3
• A 2019 randomized trial demonstrated that targeting FPG of 3.9-6.1 mmol/L (70-110 mg/dL) optimized HbA1c achievement (<7.0%) while maintaining acceptable hypoglycemia rates 4
• The 2012 ADA/EASD position statement suggests titrating basal insulin against fasting glucose targets without specifying an upper limit, implying tighter control when appropriate 5

For healthy older adults (few comorbidities, intact cognition/function), an HbA1c target of <7.0-7.5% is reasonable, which may require fasting glucose targets closer to 90-130 mg/dL 1.

Less Stringent Targets for High-Risk Patients

For older adults with complex/intermediate health status (multiple comorbidities, 2+ instrumental ADL impairments, mild-moderate cognitive impairment), the guidelines explicitly state to adjust goals based on overall health and goals of care 1, 2.

Key considerations for liberalizing targets:

• Severe or recurrent hypoglycemia history - This is an absolute indication to raise targets regardless of HbA1c
• Cognitive or functional impairment - Limits self-management ability and increases hypoglycemia consequences
• Limited life expectancy - Microvascular benefit requires years to manifest
• Polypharmacy burden - Simplification may take priority over tight control

An older study from 1984 suggested raising blood glucose standards by 10 mg/dL per decade starting at age 60 to minimize hypoglycemia risk 6, though current guidelines provide more nuanced, individualized approaches.

Critical Safety Thresholds

Regardless of the upper target chosen:

• Always reduce insulin if fasting glucose drops below 80 mg/dL on multiple occasions 1, 2
• Never target fasting glucose below 70 mg/dL (3.9 mmol/L) - This is the threshold for level 1 hypoglycemia
• Monitor for hypoglycemia unawareness, which necessitates higher targets

Common Pitfalls to Avoid

1. Over-titration in older adults: The 90-150 mg/dL range prevents the dangerous pursuit of normal fasting glucose in patients at high risk for hypoglycemia
2. Ignoring postprandial excursions: If fasting glucose is at target but HbA1c remains elevated, consider adding prandial insulin rather than further increasing basal doses 5
3. Excessive basal insulin doses: When basal insulin exceeds 0.5 U/kg/day (approaching 1 U/kg/day), prandial coverage becomes necessary rather than continuing to escalate basal doses 5
4. Fixed targets without reassessment: Guidelines emphasize that goals should be reassessed regularly based on changing health status 7

Algorithm for Target Selection

1. Start with 90-150 mg/dL for all patients as the default safe range
2. Consider tightening to 90-130 mg/dL if:
   • Age <65 years
   • No history of hypoglycemia
   • Good cognitive/functional status
   • Life expectancy >10 years
   • Patient motivated for intensive management
3. Maintain or liberalize to 100-180 mg/dL if:
   • Age ≥75 years
   • History of severe hypoglycemia
   • Cognitive impairment or limited self-management ability
   • Multiple comorbidities
   • Limited life expectancy
   • Hypoglycemia unawareness

The evidence strongly supports that individualization based on hypoglycemia risk and functional status is more important than age alone when setting targets 1, 2.